title: PharmGKB summary: fluoropyrimidine pathways.
authors.affiliation: Department of Genetics, Stanford University Medical Center, Stanford, California, USA.
authors.forename: Caroline F
authors.initials: CF
authors.lastname: Thorn
authors.forename: Sharon
authors.initials: S
authors.lastname: Marsh
authors.forename: Michelle Whirl
authors.initials: MW
authors.lastname: Carrillo
authors.forename: Howard L
authors.initials: HL
authors.lastname: McLeod
authors.forename: Teri E
authors.initials: TE
authors.lastname: Klein
authors.forename: Russ B
authors.initials: RB
authors.lastname: Altman
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000493:pharmacokinetics*; D000069287:Capecitabine; D016208:Databases, Factual; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000493:pharmacokinetics*; D015894:Genome, Human; D006801:Humans; D010597:Pharmacogenetics; D005641:Tegafur / Q000493:pharmacokinetics
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D005641:Tegafur; D000069287:Capecitabine; D005472:Fluorouracil